Summary
- Current Price
- As of today, XENE price is $62.76, up +49.64% on
- Current Price All-Time High
- XENE price is currently -0.25% below its historical high of $62.91 set on
- Market Cap
- XENE current market cap is $5B, up +73.59% over the past 365 days
- PE Ratio
- XENE PE ratio is unknown
- Revenue
- XENE current annual revenue is $7.50M, up +100.00% year-over-year
- Next Earnings
- The next earnings release for XENE is on
Profile
| Metric | Value |
|---|---|
| Full Name | Xenon Pharmaceuticals Inc. |
| Ticker | NASDAQ: XENE |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Canada |
| IPO | |
| Indexes | Not included |
| Website | xenon-pharma.com |
| Employees | 316 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $62.76 | |
| Price, 1D Change | +49.64% | |
| $5B | ||
| - | ||
| - | ||
| 1.02 | ||
| $8M | ||
| Revenue, 1Y Change | +100.00% | |
| -$4.36 | ||
| EPS, 1Y Change | -45.09% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$4.36 | ||
| EPS Estimate | N/A | -$4.84 |
| EPS Est. Change | N/A | -10.94% |
| $7.50M | ||
| Revenue Estimate | N/A | $5.79M |
| Revenue Est. Change | N/A | -22.82% |
| Current Price | $62.76 | |
| Price Target | - | $56.25 |
| Price Tgt. Change | - | -10.37% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.10 | -$3.01 | +3.03% | |
| -$4.27 | -$4.36 | -2.23% | |
| -$4.84 | N/A | -10.94% | |
| -$4.57 | N/A | -4.60% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $312.50K | $0.00 | -100.00% | |
| $7.50M | $7.50M | 0.00% | |
| $5.79M | N/A | -22.82% | |
| $88.97M | N/A | +1,086.33% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $62.76 | |
| $38.49 | ||
| SMA 200 vs Price | -38.67% | |
| $42.78 | ||
| SMA 50 vs Price | -31.84% | |
| 1.02 | ||
| $3.27 | ||
| 82.89 | ||
| 253.25% | ||
| 65.68% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $7.50M | ||
| -$4.36 | ||
| $4.96M | ||
| 66.09% | ||
| -$373.07M | ||
| -4,974.27% | ||
| -$345.91M | ||
| -4,612.13% | ||
| -$370.53M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.01 | ||
| 13.42 | ||
| 13.42 | ||
| - | ||
| - | ||
| 4.89 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 646.64 | ||
| 8.34 | ||
| -11.63 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $581.76M | ||
| $548.89M | ||
| $981.67M | ||
| $560.65M | ||
| $399.91M | ||
| $41.79M | ||
| $7.94M | ||
| $1.53M | ||
| $3.89M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $353.41M | ||
| $378.03M | ||
| $2.54M | ||
| $79.63M | ||
| $2.54M | ||
| $0.00 | ||
| $1.02M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$279.12M | ||
| $218.00M | ||
| $117.11M | ||
| $799.00K | ||
| -$279.92M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wells Fargo | → | |
| Needham | → | |
| Wolfe Research | ||
| JP Morgan | → | |
| Wells Fargo | → | |
| JP Morgan | → | |
| Wells Fargo | → | |
| RBC Capital | → | |
| Needham | → | |
| Chardan Capital | → |
Analyst sentiment
Institutional ownership
Screeners with XENE
FAQ
What is the ticker symbol for Xenon Pharmaceuticals Inc.?
The ticker symbol for Xenon Pharmaceuticals Inc. is NASDAQ:XENE
Does Xenon Pharmaceuticals Inc. pay dividends?
No, Xenon Pharmaceuticals Inc. does not pay dividends
What sector is Xenon Pharmaceuticals Inc. in?
Xenon Pharmaceuticals Inc. is in the Healthcare sector
What industry is Xenon Pharmaceuticals Inc. in?
Xenon Pharmaceuticals Inc. is in the Biotechnology industry
What country is Xenon Pharmaceuticals Inc. based in?
Xenon Pharmaceuticals Inc. is headquartered in Canada
When did Xenon Pharmaceuticals Inc. go public?
Xenon Pharmaceuticals Inc. initial public offering (IPO) was on November 5, 2014
Is Xenon Pharmaceuticals Inc. in the S&P 500?
No, Xenon Pharmaceuticals Inc. is not included in the S&P 500 index
Is Xenon Pharmaceuticals Inc. in the NASDAQ 100?
No, Xenon Pharmaceuticals Inc. is not included in the NASDAQ 100 index
Is Xenon Pharmaceuticals Inc. in the Dow Jones?
No, Xenon Pharmaceuticals Inc. is not included in the Dow Jones index
When was Xenon Pharmaceuticals Inc. last earnings report?
Xenon Pharmaceuticals Inc.'s most recent earnings report was on February 26, 2026
When does Xenon Pharmaceuticals Inc. report earnings?
The next expected earnings date for Xenon Pharmaceuticals Inc. is May 11, 2026
Data Sources & References
- XENE Official Website www.xenon-pharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1582313/000119312526076650/0001193125-26-076650-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1582313/000119312526076650/0001193125-26-076650-index.htm
- XENE Profile on Yahoo Finance finance.yahoo.com/quote/XENE
- XENE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/xene